| Literature DB >> 28916706 |
Zhi F An1,2, Deng B Wei3,2,4, Lian Wei4, Yang Wang2, Lin N Wei4.
Abstract
The plateau pika (Ochotona curzoniae) is a species of sprint-running alpine animals in the Qinghai-Tibet Plateau, which is a harsh highland hypoxic environment. Ldh-c is expressed in the testis, sperm and somatic tissues of plateau pika. To reveal the role and physiological mechanisms of sperm-specific lactate dehydrogenase (LDH-C4), in plateau pika to adapt to hypoxic environment, an adenoviral line of pMultiRNAi-Ldhc was constructed and injected into the bilateral biceps femoris of the hind legs. The swimming times of the pikas, and the Ldh-c expression levels, total LDH activities and ATP levels in skeletal muscle, were measured after the pikas were raised in the trapped site for 5 days. Our results showed that after Ldh-c was silenced, the sprint-running ability (swimming time) of the plateau pikas was significant decreased, and the total LDH activities and ATP levels were reduced by 28.21% and 27.88%, respectively. Our results indicated that expression of Ldh-c in the skeletal muscle of plateau pika increased anaerobic glycolysis and enhanced adaptation to highland hypoxic environments.Entities:
Keywords: Hypoxia; Ldh-c; Plateau pika (Ochotona curzoniae); Qinghai-Tibet Plateau; Skeletal muscle
Year: 2017 PMID: 28916706 PMCID: PMC5612231 DOI: 10.1242/bio.024943
Source DB: PubMed Journal: Biol Open ISSN: 2046-6390 Impact factor: 2.422
Fig. 1.Swimming time of plateau pika in the different treatment groups. The swimming times of the C, NS and siRNA-Ldhc groups were 633±128 s, 643±140 s and 476±92 s, respectively. *P<0.05. Water temperature, 9-10°C. The sample size was eight for each group.
Fig. 2.Quantification of (A) The electrophoresis results of real-time PCR for Ldh-a, Ldh-b, Ldh-c and β-actin in plateau pika skeletal muscle. (B) Quantification of Ldh-a mRNA expression levels in plateau pika skeletal muscle. The C, NS and siRNA-Ldhc group results were 1.00±0.11, 0.94±0.28 and 1.15±0.19, respectively. (C) Quantification of Ldh-b mRNA expression levels in plateau pika skeletal muscle. The C, NS and siRNA-Ldhc group results were 1.00±0.19, 1.04±0.24 and 0.95±0.21, respectively. (D) Quantification of Ldh-c mRNA expression levels in plateau pika skeletal muscle. The C, NS and siRNA-Ldhc group results were 1.00±0.05, 0.97±0.12 and 0.18±0.04, respectively. (E) Interference efficiency of Ldh-c after RNAi. The interference efficiency of the NS group and siRNA-Ldhc group was 2.80±0.45% and 82.18±3.52%, respectively. **P<0.01; n.s., not significant. The sample size was eight for each group.
Fig. 3.Quantification of LDHC levels in plateau pika skeletal muscle of the different treatment groups. (A) Western blot analysis of LDHC and GAPDH protein in plateau pika skeletal muscle. (B) Quantification of LDHC protein expression levels in plateau pika skeletal muscle. The C, NS and siRNA-Ldhc group results were 2.93±0.34, 3.25±0.22 and 0.53±0.21, respectively. (C) The interference efficiency of siRNA on LDHC expression in the NS group and siRNA-Ldhc group was –6.99±13.83% and 82.29±9.20%, respectively, compared to the C group. **P<0.01; n.s., not significant. The sample was eight for each group.
Fig. 4.LDH isozyme electrophoresis, LDH activities, LD content and ATP levels in pika skeletal muscle. (A) LDH isozyme electrophoresis. Lanes C, NS and siRNA-Ldhc represent the skeletal muscle in the groups; M, marker (the serum of pikas). (B) LDH activities of the C, S-C, NS, S-NS, siRNA-Ldhc and S-siRNA-Ldhc groups were 10.333±1.389 U/mg, 10.049±0.582 U/mg, 10.430±0.869 U/mg, 10.656±1.319 U/mg, 7.269±0.931 U/mg and 7.584±0.861 U/mg, respectively. (C) LD content of the C, S-C, NS, S-NS, siRNA-Ldhc and S-siRNA-Ldhc groups was 0.89±0.14 mmol/g, 1.12±0.17 mmol/g, 0.84±0.13 mmol/g, 1.08±0.18 mmol/g, 0.44±0.06 mmol/g and 0.57±0.08 mmol/g, respectively. (D) ATP levels of the C, S-C, NS, S-NS, siRNA-Ldhc and S-siRNA-Ldhc groups were 11.909±1.231 nmol/mg, 10.691±1.033 nmol/mg, 11.854±0.807 nmol/mg, 10.716±0.801 nmol/mg, 8.868±1.066 nmol/mg and 7.459±0.566 nmol/mg, respectively. (E) The interference levels of siRNA on LDH activity, LD content and ATP level were 28.21±1.10%, 48.38±3.29% and 27.88±2.33%, respectively. *P<0.05; **P<0.01; n.s., not significant. The sample size was eight for each group.